- Motley Fool•yesterday
Issues with programs developed in collaboration with Sanofi kept the otherwise promising biotech stock depressed.
- Investor's Business Daily•3 days ago
Amgen will likely triumph in a patent battle with Regeneron and Sanofi, Leerink says.
- Investopedia•3 days ago
Sanofi and ImmuNext signed a drug development deal worth up to $500 million.
SNY : Summary for Sanofi American Depositary Shar - Yahoo Finance
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||41.29 - 41.71|
|52 Week Range||36.81 - 44.50|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||24.10|
|Dividend & Yield||1.66 (4.01%)|
|1y Target Est||N/A|